Cargando…
Current vaccine strategies against SARS-CoV-2: Promises and challenges
In the years since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic began and spread across the globe, lessons have been learned about the challenges and opportunities that a pandemic brings to humankind. Researchers have produced many vaccines at unprecedented speed to prot...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126615/ https://www.ncbi.nlm.nih.gov/pubmed/35618046 http://dx.doi.org/10.1016/j.jaci.2022.05.008 |
_version_ | 1784712164656807936 |
---|---|
author | Kurup, Drishya Myers, Jacob Schnell, Matthias J. |
author_facet | Kurup, Drishya Myers, Jacob Schnell, Matthias J. |
author_sort | Kurup, Drishya |
collection | PubMed |
description | In the years since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic began and spread across the globe, lessons have been learned about the challenges and opportunities that a pandemic brings to humankind. Researchers have produced many vaccines at unprecedented speed to protect people, but they have also been cognizant of the challenges presented by a new and unexpected infectious disease. The scope of this review is to examine the path of vaccine discovery so far and identify potential targets. Here, we provide insight into the leading vaccines and their advantages and challenges. We discuss the emerging mutations within the SARS-CoV-2 spike protein and other issues that need to be addressed to overcome coronavirus disease 2019 (COVID-19) completely. Future research is needed to develop a cheap, temperature-stable vaccine providing long-term immunity that protects the upper respiratory tract. |
format | Online Article Text |
id | pubmed-9126615 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-91266152022-05-24 Current vaccine strategies against SARS-CoV-2: Promises and challenges Kurup, Drishya Myers, Jacob Schnell, Matthias J. J Allergy Clin Immunol Rostrum In the years since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic began and spread across the globe, lessons have been learned about the challenges and opportunities that a pandemic brings to humankind. Researchers have produced many vaccines at unprecedented speed to protect people, but they have also been cognizant of the challenges presented by a new and unexpected infectious disease. The scope of this review is to examine the path of vaccine discovery so far and identify potential targets. Here, we provide insight into the leading vaccines and their advantages and challenges. We discuss the emerging mutations within the SARS-CoV-2 spike protein and other issues that need to be addressed to overcome coronavirus disease 2019 (COVID-19) completely. Future research is needed to develop a cheap, temperature-stable vaccine providing long-term immunity that protects the upper respiratory tract. American Academy of Allergy, Asthma & Immunology 2022-07 2022-05-23 /pmc/articles/PMC9126615/ /pubmed/35618046 http://dx.doi.org/10.1016/j.jaci.2022.05.008 Text en © 2022 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Rostrum Kurup, Drishya Myers, Jacob Schnell, Matthias J. Current vaccine strategies against SARS-CoV-2: Promises and challenges |
title | Current vaccine strategies against SARS-CoV-2: Promises and challenges |
title_full | Current vaccine strategies against SARS-CoV-2: Promises and challenges |
title_fullStr | Current vaccine strategies against SARS-CoV-2: Promises and challenges |
title_full_unstemmed | Current vaccine strategies against SARS-CoV-2: Promises and challenges |
title_short | Current vaccine strategies against SARS-CoV-2: Promises and challenges |
title_sort | current vaccine strategies against sars-cov-2: promises and challenges |
topic | Rostrum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126615/ https://www.ncbi.nlm.nih.gov/pubmed/35618046 http://dx.doi.org/10.1016/j.jaci.2022.05.008 |
work_keys_str_mv | AT kurupdrishya currentvaccinestrategiesagainstsarscov2promisesandchallenges AT myersjacob currentvaccinestrategiesagainstsarscov2promisesandchallenges AT schnellmatthiasj currentvaccinestrategiesagainstsarscov2promisesandchallenges |